Parallel Advisors’s Annexon ANNX Stock Holding History

Parallel Advisors’s Portfolio ANNX Stock Details ANNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-122	Closed	-$875	–	3321
2024 Q1	$875	Buy	+122	New	+$633	﹤0.01%	2961

Other funds holding ANNX

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Parallel Advisors's ANNX Position: Q2 2024 in Review

Parallel Advisors sold out of Annexon (ANNX) in Q2 2024, closing a stake of 122 shares — an estimated $875 sold.

Parallel Advisors first reported a position in ANNX in Q1 2024 and held it in 1 quarter. The position peaked at $875 in Q1 2024. 140 funds tracked by Wall St. Rank hold ANNX as of Q2 2024.

Parallel Advisors reported no remaining Annexon position as of Q2 2024 after selling out during the quarter.
Parallel Advisors sold 122 Annexon shares in Q2 2024, an estimated $875.
Parallel Advisors first reported a position in Annexon in Q1 2024 and held it in 1 quarter.
Parallel Advisors's Annexon position peaked at $875 in Q1 2024.
140 funds tracked by Wall St. Rank held Annexon as of Q2 2024.

Based on Parallel Advisors's 13F filing for Q2 2024, filed 8 Aug 2024.